Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marijana Nesic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomed Research International|July 26, 2021
Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma SamplesMarijana Nesic, Julie S Bødker, Simone K Terp, et al.
Expert Review of Hematology|April 16, 2020
Mutational landscape of immune surveillance genes in diffuse large B-cell lymphomaMarijana Nesic, Tarec Christoffer El-Galaly, Martin Bøgsted, et al.
BMC Cancer|July 19, 2021
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLsMarijana Nesic, Mads Sønderkær, Rasmus Froberg Brøndum, et al.
International Journal of Cancer|April 16, 2024
Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detectionMarijana Nesic, Mads H Rasmussen, Tenna V Henriksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2025
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna V Henriksen, Christina Demuth, Amanda Frydendahl, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
British Journal of Cancer|October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomed Research International|July 26, 2021
Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma SamplesMarijana Nesic, Julie S Bødker, Simone K Terp, et al.
Expert Review of Hematology|April 16, 2020
Mutational landscape of immune surveillance genes in diffuse large B-cell lymphomaMarijana Nesic, Tarec Christoffer El-Galaly, Martin Bøgsted, et al.
BMC Cancer|July 19, 2021
The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLsMarijana Nesic, Mads Sønderkær, Rasmus Froberg Brøndum, et al.
International Journal of Cancer|April 16, 2024
Beyond basics: Key mutation selection features for successful tumor-informed ctDNA detectionMarijana Nesic, Mads H Rasmussen, Tenna V Henriksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2025
Timing of ctDNA Analysis Aimed at Guiding Adjuvant Treatment in Colorectal CancerTenna V Henriksen, Christina Demuth, Amanda Frydendahl, et al.
Nature Communications|November 21, 2025
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell typesLudvig Renbo Olsen, Denis Odinokov, Jakob Qvortrup Holsting, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
British Journal of Cancer|October 10, 2024
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancerNadia Øgaard, Sarah Østrup Jensen, Mai-Britt Worm Ørntoft, et al.
Pageof 1